Position in AVIR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,242,129
+$524,718 QoQ
Shares Held
267,125
+100.3% QoQ
Ownership
0.333%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 125 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 0%
Shared 99%
None 1%
Common Shares in AVIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. AVIR ranks #141 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in AVIR
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,242,129 | 267,125 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $717,411 | 133,348 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $313,822 | 87,906 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $360,712 | 124,384 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $540,725 | 150,202 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $517,735 | 173,156 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $658,951 | 196,702 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $651,671 | 194,529 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $645,572 | 195,037 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $792,906 | 196,264 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $675,772 | 221,565 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $636,333 | 212,111 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $787,381 | 210,530 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $726,191 | 216,774 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $711,537 | 147,929 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $663,681 | 116,640 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $860,036 | 121,132 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $758,229 | 105,018 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $297,638 | 33,293 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $11,134,319 | 317,579 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $468,220 | 21,798 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $527,468 | 8,542 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||